Form 4: Caris Life Sciences Director Buys Shares
Insider Transaction (Form 4)
Jon Halbert, a Director of Caris Life Sciences, Inc., purchased 68,000 shares of common stock on May 15, 2026 for $14.56 per share.
Summary
- Open-market purchase: acquired 68,000 Common Stock at $14.56 ($990,080) on May 15, 2026; holds 704,598 after (Indirect).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $990,080, committing personal capital to the stock.
Insider Transactions
Jon Halbert — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-05-15 | Open-market purchase | Common Stock | 68,000 | $15 | $990.1K | 704,598 |
Key Dates
| Date | Description |
|---|---|
| 2026-05-15 | Open-market purchase (68,000 shares) |
Keywords
insider transaction, Form 4, CAI, Caris Life Sciences, Inc., bullish, Jon Halbert
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.